Vor Biopharma Inc. (VOR)

AI Score

Unlock

0.74

-0.02 (-2.52%)

At close: Apr 24, 2025, 3:59 PM

0.73

-0.71%

After-hours: Apr 24, 2025, 05:19 PM EDT

Vor Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	81.95M	52.8M	76.08M	44.96M	31.36M	45.03M	32.21M	42.45M	57.71M	60.83M	62.95M	90.04M	119.8M	143.03M	169.52M	262.57M	48.54M	63.6M	72.91M	-6.47M	6.47M	-929K
Short-Term Investments	9.98M	10.01M	9.86M	62.52M	105.81M	115.07M	154.69M	167.75M	172.54M	75.24M	88.14M	91.58M	87.67M	82.93M	75.12M	n/a	n/a	n/a	n/a	12.93M	n/a	1.86M
Long-Term Investments	n/a	n/a	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	2.41M	87.67M	2.41M	1.56M	1.56M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.8M	4.92M	3.06M	4.82M	4.81M	4.09M	3.27M	2.79M	2.92M	2.88M	2.38M	8.19M	-82M	2.14M	2.11M	2.58M	4.96M	1.91M	1.56M	-6.47M	1.56M	-929K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	380K	285K	272K	507K	3.63M	667K	539K	459K	2.34M	1.77M	2.29M	2.21M	2.09M	749K	65K	92K	100K	219K	1.9M	n/a	205K	n/a
Total Current Assets	96.51M	67.3M	90.26M	111.82M	140.8M	164.44M	191.39M	216.9M	236.95M	142.73M	158.84M	190.3M	214.4M	232.07M	249.26M	266.26M	49.11M	65.52M	74.81M	6.47M	7.54M	929K
Property-Plant & Equipment	41.59M	43.77M	45.86M	47.98M	50.1M	52.09M	53.91M	55.43M	57.08M	58.35M	60.97M	33.36M	22.52M	22.01M	22.21M	22.53M	21.84M	21.09M	19.81M	n/a	728K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	46.38M	48.7M	51.33M	55.21M	69.03M	58.59M	59.59M	60.63M	62.42M	63.64M	65.77M	43.97M	28.19M	26.56M	25.88M	26.67M	26.8M	23M	21.37M	-6.47M	2.29M	-929K
Total Assets	142.89M	115.99M	141.59M	167.03M	209.83M	223.02M	250.99M	277.53M	299.37M	206.37M	224.62M	234.27M	242.59M	258.63M	275.14M	292.94M	75.91M	88.53M	96.19M	n/a	9.83M	n/a
Account Payables	1.5M	1.32M	2.01M	2.33M	815K	1.31M	1.65M	3.22M	1.77M	824K	1.27M	1.25M	1.54M	1.96M	2.37M	2.41M	2.36M	2.32M	1.66M	n/a	693K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	9.92M	7.11M	n/a	n/a	n/a	n/a	n/a	6.33M	5.68M	4.29M	4.39M	6.26M	4.15M	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	4.11M	n/a	3.83M	3.74M	3.69M	3.71M	n/a	3.76M	4.43M	7.28M	1.84M	1.15M	1.16M	1.16M	863K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	6.21M	8.87M	160K	5.02M	2.46M	2.32M	564K	361K	3.67M	-319K	-473K	42K	3.39M	3.12M	1.63M	2.32M	3.39M	2.27M	2.29M	n/a	900K	n/a
Total Current Liabilities	18.61M	14.35M	13.8M	13.21M	15.57M	15.39M	12.72M	12.58M	13.12M	11.1M	12.26M	18.14M	10.15M	9.21M	8.3M	8.63M	10.21M	7.6M	3.95M	n/a	2.19M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	31.83M	32.85M	33.82M	34.74M	n/a	36.54M	37.38M	21.68M	16.17M	16.46M	16.73M	17.12M	17.43M	n/a	17.9M	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	-31.83M	-32.85M	-33.82M	-34.74M	n/a	-36.54M	-37.38M	-21.68M	-16.17M	-16.46M	-16.73M	-17.12M	-17.43M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	27.61M	28.69M	29.71M	30.78M	43.53M	32.85M	33.82M	34.74M	35.64M	36.54M	37.38M	21.68M	16.17M	16.46M	16.73M	17.12M	17.43M	17.73M	17.9M	n/a	n/a	n/a
Total Liabilities	46.23M	43.04M	43.51M	43.99M	59.1M	48.24M	46.54M	47.32M	48.76M	47.64M	49.64M	39.82M	26.33M	25.68M	25.04M	25.75M	27.64M	25.33M	21.84M	n/a	2.19M	n/a
Total Debt	31.83M	32.85M	33.82M	34.74M	35.66M	36.6M	37.51M	38.45M	38.91M	40.29M	41.81M	28.96M	18.01M	17.61M	17.89M	18.28M	18.29M	18.44M	17.9M	n/a	n/a	n/a
Common Stock	13K	7K	7K	7K	7K	7K	7K	7K	7K	4K	4K	4K	4K	4K	4K	4K	1K	n/a	n/a	n/a	1.00	n/a
Retained Earnings	-456.99M	-426.28M	-398.72M	-370.88M	-340.08M	-313.82M	-280.63M	-250.65M	-222.22M	-198.31M	-174.52M	-152.86M	-130.12M	-111.87M	-93.32M	-74.95M	-61.22M	-45.56M	-33.78M	n/a	-17.89M	n/a
Comprehensive Income	22K	68K	-70K	-87K	-77K	-280K	-436K	-174K	-770K	-1.18M	-1.33M	-1.07M	n/a	-258.63M	-275.14M	-292.94M	n/a	n/a	n/a	-17.43M	0.00	-6.77M
Shareholders Equity	96.66M	72.95M	98.08M	123.03M	150.72M	174.78M	204.45M	230.22M	250.61M	158.73M	174.97M	194.45M	216.26M	232.96M	250.11M	267.19M	48.27M	63.19M	74.34M	7.64M	7.64M	-6.77M
Total Investments	9.98M	10.01M	12.28M	64.93M	108.23M	115.07M	154.69M	167.75M	172.54M	75.24M	88.14M	91.58M	87.67M	82.93M	75.12M	1.56M	n/a	n/a	n/a	12.93M	n/a	1.86M